Ohcanbohtosat - Elizabeth Berry‐Kravis

Aiddostahte ozu
  1. 1
    Epilepsy in fragile X syndrome

    Epilepsy in fragile X syndrome Dahkki Elizabeth Berry‐Kravis

    Almmustuhtton 2002
    Viečča ollesdeavstta
    Artigo
    Lasit oiddohiidda
    Furkejuvvon:
  2. 2
    Targeted treatments for fragile X syndrome

    Targeted treatments for fragile X syndrome Dahkki Elizabeth Berry‐Kravis, Andrew Knox, Crystal Hervey

    Almmustuhtton 2011
    Viečča ollesdeavstta Viečča ollesdeavstta
    Artigo
    Lasit oiddohiidda
    Furkejuvvon:
  3. 3
    Therapeutic Strategies in Fragile X Syndrome: Dysregulated mGluR Signaling and Beyond

    Therapeutic Strategies in Fragile X Syndrome: Dysregulated mGluR Signaling and Beyond Dahkki Christina Groß, Elizabeth Berry‐Kravis, Gary J. Bassell

    Almmustuhtton 2011
    Viečča ollesdeavstta Viečča ollesdeavstta
    Revisão
    Lasit oiddohiidda
    Furkejuvvon:
  4. 4
    Fragile X: Leading the Way for Targeted Treatments in Autism

    Fragile X: Leading the Way for Targeted Treatments in Autism Dahkki Lulu W. Wang, Elizabeth Berry‐Kravis, Randi J. Hagerman

    Almmustuhtton 2010
    Viečča ollesdeavstta Viečča ollesdeavstta
    Revisão
    Lasit oiddohiidda
    Furkejuvvon:
  5. 5
    Clinic-Based Retrospective Analysis of Psychopharmacology for Behavior in Fragile X Syndrome

    Clinic-Based Retrospective Analysis of Psychopharmacology for Behavior in Fragile X Syndrome Dahkki Elizabeth Berry‐Kravis, Allison Sumis, Crystal Hervey, Shaguna Mathur

    Almmustuhtton 2012
    Viečča ollesdeavstta Viečča ollesdeavstta
    Artigo
    Lasit oiddohiidda
    Furkejuvvon:
  6. 6
    Therapeutic Strategies in Fragile X Syndrome: From Bench to Bedside and Back

    Therapeutic Strategies in Fragile X Syndrome: From Bench to Bedside and Back Dahkki Christina Groß, Anne Hoffmann, Gary J. Bassell, Elizabeth Berry‐Kravis

    Almmustuhtton 2015
    Viečča ollesdeavstta Viečča ollesdeavstta
    Revisão
    Lasit oiddohiidda
    Furkejuvvon:
  7. 7
    A developmental, longitudinal investigation of autism phenotypic profiles in fragile X syndrome

    A developmental, longitudinal investigation of autism phenotypic profiles in fragile X syndrome Dahkki Michelle Lee, Gary E. Martin, Elizabeth Berry‐Kravis, Molly Losh

    Almmustuhtton 2016
    Viečča ollesdeavstta Viečča ollesdeavstta
    Artigo
    Lasit oiddohiidda
    Furkejuvvon:
  8. 8
    Fragile X Syndrome and Targeted Treatment Trials

    Fragile X Syndrome and Targeted Treatment Trials Dahkki Randi J. Hagerman, Julie C. Lauterborn, Jacky Au, Elizabeth Berry‐Kravis

    Almmustuhtton 2011
    Viečča ollesdeavstta
    Revisão
    Lasit oiddohiidda
    Furkejuvvon:
  9. 9
    Early‐phase ERK activation as a biomarker for metabolic status in fragile X syndrome

    Early‐phase ERK activation as a biomarker for metabolic status in fragile X syndrome Dahkki Ning Weng, Ivan Jeanne Weiler, Allison Sumis, Elizabeth Berry‐Kravis, William T. Greenough

    Almmustuhtton 2008
    Viečča ollesdeavstta Viečča ollesdeavstta
    Artigo
    Lasit oiddohiidda
    Furkejuvvon:
  10. 10
    Reliability of Eye Tracking and Pupillometry Measures in Individuals with Fragile X Syndrome

    Reliability of Eye Tracking and Pupillometry Measures in Individuals with Fragile X Syndrome Dahkki Faraz Farzin, Felicia Scaggs Huang, Crystal Hervey, Elizabeth Berry‐Kravis, David Hessl

    Almmustuhtton 2011
    Viečča ollesdeavstta Viečča ollesdeavstta
    Artigo
    Lasit oiddohiidda
    Furkejuvvon:
  11. 11
    Neuropsychiatric decompensation in adolescents and adults with Phelan-McDermid syndrome: a systematic review of the literature

    Neuropsychiatric decompensation in adolescents and adults with Phelan-McDermid syndrome: a systematic review of the literature Dahkki Alexander Kolevzon, Elsa Delaby, Elizabeth Berry‐Kravis, Joseph D. Buxbaum, Catalina Betancur

    Almmustuhtton 2019
    Viečča ollesdeavstta Viečča ollesdeavstta
    Revisão
    Lasit oiddohiidda
    Furkejuvvon:
  12. 12
    Cholesterol levels in Fragile X syndrome

    Cholesterol levels in Fragile X syndrome Dahkki Elizabeth Berry‐Kravis, Rebecca Levin, Haroon Shah, Shaguna Mathur, Jennifer C. Darnell, Bichun Ouyang

    Almmustuhtton 2014
    Viečča ollesdeavstta Viečča ollesdeavstta
    Artigo
    Lasit oiddohiidda
    Furkejuvvon:
  13. 13
    Improving IQ measurement in intellectual disabilities using true deviation from population norms

    Improving IQ measurement in intellectual disabilities using true deviation from population norms Dahkki Stephanie M. Sansone, Andrea Schneider, Erika Bickel, Elizabeth Berry‐Kravis, Christina R. Prescott, David Hessl

    Almmustuhtton 2014
    Viečča ollesdeavstta Viečča ollesdeavstta
    Artigo
    Lasit oiddohiidda
    Furkejuvvon:
  14. 14
    Feasibility, reliability, and clinical validity of the Test of Attentional Performance for Children (KiTAP) in Fragile X syndrome (FXS)

    Feasibility, reliability, and clinical validity of the Test of Attentional Performance for Children (KiTAP) in Fragile X syndrome (FXS) Dahkki Andrew Knox, Andrea Schneider, Floridette Abucayan, Crystal Hervey, Christina Tran, David Hessl, Elizabeth Berry‐Kravis

    Almmustuhtton 2012
    Viečča ollesdeavstta Viečča ollesdeavstta
    Artigo
    Lasit oiddohiidda
    Furkejuvvon:
  15. 15
    Outcome Measures for Clinical Trials in Fragile X Syndrome

    Outcome Measures for Clinical Trials in Fragile X Syndrome Dahkki Elizabeth Berry‐Kravis, David Hessl, Leonard Abbeduto, Allan L. Reiss, Andrea Beckel‐Mitchener, Tiina K. Urv

    Almmustuhtton 2013
    Viečča ollesdeavstta
    Artigo
    Lasit oiddohiidda
    Furkejuvvon:
  16. 16
    Voice of People with Fragile X Syndrome and Their Families: Reports from a Survey on Treatment Priorities

    Voice of People with Fragile X Syndrome and Their Families: Reports from a Survey on Treatment Priorities Dahkki Jayne Dixon Weber, Elizabeth G. Smith, Elizabeth Berry‐Kravis, Diego Cadavid, David Hessl, Craig A. Erickson

    Almmustuhtton 2019
    Viečča ollesdeavstta Viečča ollesdeavstta
    Artigo
    Lasit oiddohiidda
    Furkejuvvon:
  17. 17
    Development of an Expressive Language Sampling Procedure in Fragile X Syndrome

    Development of an Expressive Language Sampling Procedure in Fragile X Syndrome Dahkki Elizabeth Berry‐Kravis, Emily R. Doll, Audra Sterling, Sara T. Kover, Susen M. Schroeder, Shaguna Mathur, Leonard Abbeduto

    Almmustuhtton 2013
    Viečča ollesdeavstta
    Artigo
    Lasit oiddohiidda
    Furkejuvvon:
  18. 18
    White matter disease and cognitive impairment in <i>FMR1</i> premutation carriers

    White matter disease and cognitive impairment in <i>FMR1</i> premutation carriers Dahkki Christopher M. Filley, Mark S. Brown, Karen Onderko, Megan Ray, Rachael E. Bennett, Elizabeth Berry‐Kravis, Jim Grigsby

    Almmustuhtton 2015
    Viečča ollesdeavstta
    Artigo
    Lasit oiddohiidda
    Furkejuvvon:
  19. 19
    The Apolipoprotein E ε4 Allele Increases the Odds of Chronic Cerebral Infarction Detected at Autopsy in Older Persons

    The Apolipoprotein E ε4 Allele Increases the Odds of Chronic Cerebral Infarction Detected at Autopsy in Older Persons Dahkki Julie A. Schneider, Julia L. Bienias, R. J. Wilson, Elizabeth Berry‐Kravis, Denis A. Evans, David A. Bennett

    Almmustuhtton 2005
    Viečča ollesdeavstta
    Artigo
    Lasit oiddohiidda
    Furkejuvvon:
  20. 20
    Activation of Peroxisome Proliferator-activated Receptor α Induces Lysosomal Biogenesis in Brain Cells

    Activation of Peroxisome Proliferator-activated Receptor α Induces Lysosomal Biogenesis in Brain Cells Dahkki Arunava Ghosh, Malabendu Jana, Khushbu K. Modi, Frank J. Gonzalez, Katherine B. Sims, Elizabeth Berry‐Kravis, Kalipada Pahan

    Almmustuhtton 2015
    Viečča ollesdeavstta
    Artigo
    Lasit oiddohiidda
    Furkejuvvon:

Ohcanreaiddut: